VHPB Centre for Evaluation of Vaccination (CEV) |
Executive Secretary Administrative and Scientific Secretariat |
privacy statement
|
7-8 November 2017 - Brussel, Belgium
Meeting objectives:
Background document - 2.9 Mb (.pdf)
Thursday 01 June
SESSION 1: OPENING AND OBJECTIVES
Chairs: Pierre Van Damme and Tatjana Reic
09:00-09:30
SESSION 2: THE HEALTH CARE SYSTEM IN BELGIUM _ LUXEMBOURG
09:30 - 09:50 Belgium
Lieven De Raedt
09:50 - 10:10 Luxembourg - 810 kb (.pdf)
Jean-Claude Schmit
10:10 - 10:30 Questions and discussion
10:30 - 10:50 Coffee break
SESSION 2: SURVEILLANCE SYSTEM AND EPIDEMIOLOGY IN BELGIUM AND LUXEMBOURG
Chairs: Erika Duffell – Vladimir Chulanov
10:50 - 11:10 Overview of surveillance system and epidemiology of hepatitis A, D and E - 636 kb (.pdf)
Steven Van Gucht
11:10 - 11:30 Overview of surveillance system and epidemiology of hepatitis B and C - 569 kb (.pdf)
Gaëtan Muyldermans
11:30 - 11:50 Overview of surveillance and epidemiology in Luxembourg - 1.4 Mb (.pdf)
Carole Devaux
11:50 - 12:10 Questions and discussion
SESSION 4: VIRAL HEPATITIS DISEASE BURDEN
12:10 - 12:30 Chronic viral hepatitis and liver disease in Belgium - 2 Mb (.pdf)
Pierre Deltenre
12:30- 12:50 Chronic viral hepatitis and liver disease in Luxembourg - 967 kb (.pdf)
Carole Devaux
12:50 - 13:10 Discussion
13:10 – 14:10 Lunch
SESSION 5: PREVENTION OF VIRAL HEPATITIS
Chairs: Daniel Shouval and Vana Papaevangelou
14:10 - 14:40 Vaccination program in Belgium (Wallonia) - 569 kb (.pdf)
Ingrid Morales
14:10 - 14:40 Vaccination program in Belgium (Flanders) - 1 Mb (.pdf)
Geert Top
14:40- 15:00 Vaccination program in Luxembourg - 305 kb (.pdf)
Françoise Berthet
15:00- 15:20 Clinics, Treatment and Prevention of viral hepatitis E. - 2.5 Mb (.pdf)
Thomas Vanwolleghem
15:20- 15:40 Hepatitis A outbreak: epidemiology and management - 1.1 Mb (.pdf)
Naïma Hammami
15:40 - 16:00 Questions & Comments
16:00- 16:20 Coffee break
SESSION 6: EPIDEMIOLOGY, PREVENTION AND CONTROL OF VIRAL HEPATITIS IN DIFFERENT RISK GROUPS
Chairs: Daniel Lavanchy and Heléne Norder
16:20 - 16:40 Prevention and control of viral hepatitis in IDU/prisoners - Belgium - 1.3 Mb (.pdf)
Cathy Matheï
16:40 - 17:00 Prevention and control of viral hepatitis in IDU/prisoners - Luxembourg - 2.1 Mb (.pdf)
Patrick Hoffmann
17:00 - 17:20 Screening and prevention of viral hepatitis in sex workers - 957 kb (.pdf)
Heleen Van Mieghem
17:20- 17:40 Do or don’t screen - Migrants: hepatitis B and C in Chinese population in Antwerp
Erwin Ho
17:40 – 18:00 Questions and comments
Wednesday 08 November
SESSION 7: CONTROL – TREATMENT VIRAL HEPATITIS IN BELGIUM -LUXEMBOURG
Chairs: Mojca Matičič – Francoise Roudot- Thoraval
08:30 – 08:50 BASL Treatment guidelines for viral hepatitis B/C - 620 kb (.pdf)
Anja Geerts (BASL)
08:50 – 09:10 Treatment habits and recommandations in Luxembourg - 1.6 Mb (.pdf)
Victor Arendt
09:10 – 09:30 Questions and comments
SESSION 8: NATIONAL HEPATITIS PLAN _ POLICIES
09:30 - 09:50 National Hepatitis plan - Belgium - 1.6 Mb (.pdf)
Jean-Pierre Mulkay
09:50 - 10:10 National Hepatitis plan - Luxembourg - 671 kb (.pdf)
Victor Arendt
10:10 - 10:30 Do or don't screen - screening in hospital emergency service
Rob Bielen
10:30 - 10:50 Questions and discussion
10:50 - 11:15 Coffee break
SESSION 9: GROUP DISCUSSION: WHAT ARE THE NEEDS TO ELIMINATE VIRAL HEPATITIS BY 2030
11:15 - 11:35 Achieving WHO recommendations for Hepatitis C Virus Elimination in Belgium - The disease burden of hepatitis C in Belgium: an update of a realistic disease control strategy - 1 Mb (.pdf)
Peter Stärkel
11:35 - 12:45 Discussion groups
12:45 - 13:15 Presentation of the results of the discussion groups
13:15 – 13:30 Questions and comments
13:30 – 14:45 Lunch
SESSION 10: CONCLUSIONS
Chairs: Mark Kane - Alessandro Zanetti
14:45– 15:35 VHPB meeting conclusions.
David FitzSimons